Lyme disease: Neurology, Neurobiology, and Behavior

Clinical Infectious Diseases

Volumn 58, Issue 9, 2014, Pages 1267-1272

  Halperin, John J ^a,b  

^a Overlook Medical Center   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Lyme disease; Lyme encephalopathy; nervous system; neuroborreliosis; posttreatment Lyme disease syndrome

Indexed keywords

BORRELIA BURGDORFERI; BORRELIA INFECTION; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM INFECTION; CHRONIC DISEASE; HUMAN; LYME DISEASE; NEUROBIOLOGY; PRIORITY JOURNAL; REVIEW; BEHAVIOR; COMPLICATION; LYME NEUROBORRELIOSIS; PATHOLOGY;

BEHAVIOR; HUMANS; LYME DISEASE; LYME NEUROBORRELIOSIS;

EID: 84898879614     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu106     Document Type: Review

References (40)

1. Marist Poll . Alzheimer's most feared disease. Available at: Http:// maristpoll.marist.edu/1114-Alzheimers-most-feared-disease/. Accessed 31 August 2013
2. Harris Interactive . What America thinks: MetLife Foundation Alzheimer's survey. Available at: Https://www.metlife.com/assets/cao/ contributions/ foundation/alzheimers-2011.pdf. Accessed 5 September 2013
3. Halperin JJ. Lyme disease: A multisystem infection that affects the nervous system. Continuum (Minneap Minn) 2012; 18 (6 Infectious Disease): 1338-50
4. Luft BJ, Steinman CR, Neimark HC, et al. Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection. JAMA 1992; 267:1364-7
5. Rupprecht TA, Plate A, Adam M, et al. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. J Neuroinflammation 2009; 6:42
6. Russell TM, Delorey MJ, Johnson BJ. Borrelia burgdorferi BbHtrA degrades host ECM proteins and stimulates release of inflammatory cytokines in vitro. Mol Microbiol 2013; 90:241-51
7. Halperin JJ, Luft BJ, Anand AK, et al. Lyme neuroborreliosis: Central nervous system manifestations. Neurology 1989; 39:753-9
8. Halperin JJ, Volkman DJ, Wu P. Central nervous system abnormalities in Lyme neuroborreliosis. Neurology 1991; 41:1571-82
9. Krupp LB, Masur D, Schwartz J, et al. Cognitive functioning in late Lyme borreliosis. Arch Neurol 1991; 48:1125-9
10. Halperin JJ, Heyes MP, Keller TL, Whitman M. Neuroborreliosis - encephalopathy vs encephalitis. In: Proceedings of the 5th International Conference on Lyme Borreliosis, Arlington, Virginia, May 1992. Abstract 1 1992:1
11. Halperin JJ, Heyes MP. Neuroactive kynurenines in Lyme borreliosis. Neurology 1992; 42:43-50
12. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006; 43:1089-134
13. Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001; 345:85-92
14. The ILADSWorking Group. Evidence-based guidelines for the management of Lyme disease. Expert Rev Anti-Infect Ther 2004; 2(suppl 1): S1-13
15. Krupp LB, Hyman LG, Grimson R, et al. Study and treatment of post Lyme disease (STOP-LD): A randomized double masked clinical trial. Neurology 2003; 60:1923-30
16. Fallon BA, Keilp JG, Corbera KM, et al. A randomized, placebocontrolled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 2008; 70:992-1003
17. Seltzer EG, Gerber MA, Cartter ML, Freudigman K, Shapiro ED. Longterm outcomes of persons with Lyme disease. JAMA 2000; 283:609-16
18. Skogman BH, Glimaker K, Nordwall M, Vrethem M, Odkvist L, Forsberg P. Long-Term clinical outcome after Lyme neuroborreliosis in childhood. Pediatrics 2012; 130:262-9
19. Nowakowski J, Nadelman RB, Sell R, et al. Long-Term follow-up of patients with culture-confirmed Lyme disease. Am J Med 2003; 115:91-6
20. Salazar JC, Gerber MA, Goff CW. Long-Term outcome of Lyme disease in children given early treatment. J Pediatr 1993; 122:591-3
21. Shadick NA, Phillips CB, Sangha O, et al. Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease. Ann Intern Med 1999; 131:919-26
22. Vazquez M, Sparrow SS, Shapiro ED. Long-Term neuropsychologic and health outcomes of children with facial nerve palsy attributable to Lyme disease. Pediatrics 2003; 112:e93-7
23. Wessely S. Chronic fatigue: Symptom and syndrome. Ann Intern Med 2001; 134(9 pt 2): 838-43
24. Luo N, Johnson J, Shaw J, Feeny D, Coons S. Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. Med Care 2005; 43:1078-86
25. Centers for Disease Control and Prevention. Lyme disease data. Available at: Http://www.cdc.gov/lyme/stats/index.html. Accessed 6 July 2013
26. Bacon RM, Kugeler KJ, Mead PS. Surveillance for Lyme disease - United States, 1992-2006. MMWR Morb Mortal Wkly Rep 2008; 57:1-9
27. Mead P, Nelson C, Hinckley A, et al. Estimating the public health burden of Lyme disease in the United States. In: 13th International Conference on Lyme Borreliosis and Other Tick-borne Diseases, Boston, MA, 2013
28. Chandra A,Wormser GP, Klempner MS, et al. Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms. Brain Behav Immun 2010; 241018-24
29. Jacek E, Fallon BA, Chandra A, Crow MK, Wormser GP, Alaedini A. Increased IFNalpha activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits. J Neuroimmunol 2013; 255:85-91
30. Embers M, Barthold S, Borda JT, et al. Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection. PLoS One 2012; 7:1-12
31. Bockenstedt LK, Gonzalez DG, Haberman AM, Belperron AA. Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy. J Clin Invest 2012; 122:2652-60
32. Parthasarathy G, Fevrier HB, Philipp MT. Non-viable Borrelia burgdorferi induce inflammatory mediators and apoptosis in human oligodendrocytes. Neurosci Lett 2013; 556:200-3
33. Wormser GP, Nadelman RB, Schwartz I. The amber theory of Lyme arthritis: Initial description and clinical implications. Clin Rheumatol 2012; 31:989-94
34. Gordon S, Eaton M, George R, et al. The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection. N Engl J Med 1994; 331: 1469-73
35. Fraser CM, Casjens S, Huang WM, et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 1997; 390:580-6
36. Fallon BA, Nields JA, Parsons B, Liebowitz MR, Klein DF. Psychiatric manifestations of Lyme borreliosis. J Clin Psychiatry 1993; 54:263-8
37. Reid MC, Schoen RT, Evans J, Rosenberg JC, Horwitz RI. The consequences of overdiagnosis and overtreatment of Lyme disease. Ann Intern Med 1998; 128:354-62
38. Hassett AL, Sigal LH. The psychology of 'post Lyme disease syndrome' and 'not Lyme.' In: Halperin JJ, ed. Lyme disease - An evidence based approach. Wallingford, UK: CABI, 2011
39. Hassett AL, Shlimbaum T, Radvanski DC, et al. A prospective, longitudinal cohort study evaluating psychosocial risk and protective factors for post Lyme disease syndrome. In: Arthritis Care & Research. Am Coll Rheum. 2010
40. Hassett AL, Radvanski DC, Buyske S, Savage SV, Sigal LH. Psychiatric comorbidity and other psychological factors in patients with "chronic Lyme disease." Am J Med 2009; 122:843-50.